Cytek BioSciences 

$4.37
23
+$0.07+1.63% Tuesday 20:00

Statistics

Day High
4.49
Day Low
4.34
52W High
6.18
52W Low
2.37
Volume
580,860
Avg. Volume
840,853
Mkt Cap
558.77M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.34
-0.19
-0.03
0.12
Expected EPS
-0.0975
Actual EPS
N/A

Financials

-3%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
400.91MRevenue
-12.04MNet Income

Analyst Ratings

$6.25Average Price Target
The highest estimate is 7.50.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CTKB. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biodesix
BDSX
Mkt Cap54.64M
Biodesix is a competitor because it also operates in the biotechnology sector focusing on diagnostic solutions, similar to Cytek's focus on cell analysis technologies.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health operates in the precision oncology field, offering liquid biopsies and cancer diagnostics that compete with Cytek's diagnostic solutions.
Illumina
ILMN
Mkt Cap18.99B
Illumina, Inc. competes with Cytek through its next-generation sequencing (NGS) technologies, which are used in genetic analysis and overlap with Cytek's cell analysis market.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Pacific Biosciences of California offers long-read sequencing technologies, competing in the broader genomics and cell analysis market that Cytek targets.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. provides sample and assay technologies for molecular diagnostics, competing with Cytek in the life sciences and molecular diagnostics sectors.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of analytical instruments and reagents, including those for cell analysis, directly competing with Cytek's product offerings.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its Life Sciences segment, offers products and services that compete with Cytek's cell analysis and cytometry solutions.
Agilon Health
AGL
Mkt Cap330.09M
Agilent Technologies provides instruments, services, and consumables for laboratories, including cell analysis technologies that compete with Cytek BioSciences.

About

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Show more...
CEO
Dr. Wenbin Jiang Ph.D.
Employees
663
Country
US
ISIN
US23285D1090

Listings

0 Comments

Share your thoughts

FAQ

What is Cytek BioSciences stock price today?
The current price of CTKB is $4.37 USD — it has increased by +1.63% in the past 24 hours. Watch Cytek BioSciences stock price performance more closely on the chart.
What is Cytek BioSciences stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cytek BioSciences stocks are traded under the ticker CTKB.
Is Cytek BioSciences stock price growing?
CTKB stock has fallen by -5% compared to the previous week, the month change is a -2.46% fall, over the last year Cytek BioSciences has showed a +11.48% increase.
What is Cytek BioSciences market cap?
Today Cytek BioSciences has the market capitalization of 558.77M
When is the next Cytek BioSciences earnings date?
Cytek BioSciences is going to release the next earnings report on May 13, 2026.
What were Cytek BioSciences earnings last quarter?
CTKB earnings for the last quarter are -0.34 USD per share, whereas the estimation was -0.02 USD resulting in a -1,600% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cytek BioSciences revenue for the last year?
Cytek BioSciences revenue for the last year amounts to 400.91M USD.
What is Cytek BioSciences net income for the last year?
CTKB net income for the last year is -12.04M USD.
How many employees does Cytek BioSciences have?
As of April 01, 2026, the company has 663 employees.
In which sector is Cytek BioSciences located?
Cytek BioSciences operates in the Health Care sector.
When did Cytek BioSciences complete a stock split?
Cytek BioSciences has not had any recent stock splits.
Where is Cytek BioSciences headquartered?
Cytek BioSciences is headquartered in Fremont, US.